Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical Intermediates Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111718372B discloses a novel axial chiral ligand enabling high-yield asymmetric allylic substitution with simplified synthesis for cost-effective API manufacturing.
Patent CN106883153B reveals a one-step synthesis for 2-sulfonyl-1,4-diphenol derivatives using NH4I, offering cost reduction and high purity for pharmaceutical intermediates.
Novel iodine-promoted route for 3,4,5-trisubstituted 1,2,4-triazoles offers metal-free efficiency and scalable production for global API manufacturers.
Patent CN114874139A details a green visible-light method for 1-benzyl-3,4-dihydroisoquinoline. Offers cost-effective, scalable pharma intermediate production.
Novel iodine-promoted method for 3,4,5-trisubstituted 1,2,4-triazoles offers cost-effective, scalable routes for API manufacturing without heavy metals.
Patent CN113549062A discloses bulky chiral quaternary ammonium salts enhancing enantioselectivity in KMnO4 oxidation, offering cost-effective API intermediate solutions.
Novel Pd-catalyzed cyclization of anilines and alkynes offers high-purity beta-halopyrroles with simplified supply chains and reduced manufacturing costs.
Novel radical amino migration patent enables mild benzolactam synthesis. Offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN102516162A reveals a green copper-catalyzed nitration method. Offers high purity, cost reduction in API manufacturing, and reliable supply chain solutions.
Novel catalytic method for C2-phosphono indoles. High atom economy, mild conditions. Reliable supplier for pharmaceutical intermediates.
Patent CN107021866A details a Lewis acid catalyzed route for chain enyne compounds. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN112694430B details a safe, high-yield palladium-catalyzed carbonylation route for bioactive pyrrolone scaffolds, offering significant supply chain advantages.
Patent CN111718372B discloses a novel axial chiral ligand enabling high-yield asymmetric allylic substitution with excellent enantioselectivity for cost-effective API manufacturing.
Novel iodine-promoted route for 3,4,5-trisubstituted 1,2,4-triazoles offers metal-free efficiency and scalable production for global API manufacturers.
Novel Mo/Cu co-catalyzed method offers mild conditions and high yields for critical API building blocks, ensuring supply chain stability.
Discover advanced ferrocene-based PNN ligands from patent CN114644663A for high-efficiency ketone hydrogenation, offering reliable supply and cost-effective pharma intermediate manufacturing.
Novel synthetic route for spiro compound intermediates ensures scalable production and cost efficiency for global pharmaceutical supply chains.
Patent CN114989063A reveals a novel Pd-catalyzed serial cyclization for beta-halopyrroles, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN108690007B details a transition metal-catalyzed C-H coupling method using ionic liquids for efficient ortho-cyanation, offering significant cost reduction in API manufacturing.
Novel one-pot method using metabisulfite and peroxides offers cost-effective, scalable production of key pharmaceutical intermediates with high purity.